Literature DB >> 1953652

Characterization of isoforms of protein 4.1 present in the nucleus.

I Correas1.   

Abstract

Although protein 4.1 was originally identified as an element of the erythrocyte membrane skeleton, its presence in most mammalian cell types is now well described. Antibodies raised against erythrocyte protein 4.1 or synthetic peptides corresponding to the spectrin-actin-binding domain of protein 4.1 react with plasma membranes and, unexpectedly, nuclei of different cell types. Nuclear staining was further confirmed in isolated nuclei prepared from rat liver and human leukaemic cell lines. Immunoblot analysis of subcellular fractions derived from these cells revealed three prominent proteins, of 80, 135 and 145 kDa. The structural relationship of the high-molecular-mass proteins with erythrocyte protein 4.1 was demonstrated by peptide mapping. These results indicate that mammalian nucleated cells contain several isoforms of erythrocyte protein 4.1 and that some high-molecular-mass forms may primarily reside in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953652      PMCID: PMC1151643          DOI: 10.1042/bj2790581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Tissue-specific analogues of erythrocyte protein 4.1 retain functional domains.

Authors:  R A Anderson; I Correas; C Mazzucco; J D Castle; V T Marchesi
Journal:  J Cell Biochem       Date:  1988-07       Impact factor: 4.429

2.  Selective expression of an erythroid-specific isoform of protein 4.1.

Authors:  T K Tang; T L Leto; I Correas; M A Alonso; V T Marchesi; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 3.  Stabilizing infrastructure of cell membranes.

Authors:  V T Marchesi
Journal:  Annu Rev Cell Biol       Date:  1985

4.  Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells.

Authors:  J G Conboy; J Chan; N Mohandas; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Erythrocyte protein 4.1 associates with tubulin.

Authors:  I Correas; J Avila
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

6.  Regulated expression of multiple chicken erythroid membrane skeletal protein 4.1 variants is governed by differential RNA processing and translational control.

Authors:  J Ngai; J H Stack; R T Moon; E Lazarides
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Mechanisms of cytoskeletal regulation: modulation of aortic endothelial cell protein band 4.1 by the extracellular matrix.

Authors:  T L Leto; B M Pratt; J A Madri
Journal:  J Cell Physiol       Date:  1986-06       Impact factor: 6.384

8.  Macromolecular domains containing nuclear protein p107 and U-snRNP protein p28: further evidence for an in situ nuclear matrix.

Authors:  H C Smith; R L Ochs; E A Fernandez; D L Spector
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

9.  Distribution of the 70K U1 RNA-associated protein during interphase and mitosis. Correlation with other U RNP particles and proteins of the nuclear matrix.

Authors:  R Verheijen; H Kuijpers; P Vooijs; W Van Venrooij; F Ramaekers
Journal:  J Cell Sci       Date:  1986-12       Impact factor: 5.285

10.  Visualization of the hexagonal lattice in the erythrocyte membrane skeleton.

Authors:  S C Liu; L H Derick; J Palek
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more
  19 in total

1.  The N-terminal 209-aa domain of high molecular-weight 4.1R isoforms abrogates 4.1R targeting to the nucleus.

Authors:  C M Luque; M J Lallena; C M Pérez-Ferreiro; Y de Isidro; G De Cárcer; M A Alonso; I Correas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

3.  Inhibition of protein 4.1 R and NuMA interaction by mutagenization of their binding-sites abrogates nuclear localization of 4.1 R.

Authors:  Subhendra N Mattagajasingh; Shu-Ching Huang; Edward J Benz
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

4.  Comprehensive characterization of expression patterns of protein 4.1 family members in mouse adrenal gland: implications for functions.

Authors:  Hua Wang; Congrong Liu; Gargi Debnath; Anthony J Baines; John G Conboy; Narla Mohandas; Xiuli An
Journal:  Histochem Cell Biol       Date:  2010-10-02       Impact factor: 4.304

5.  Protein 4.1R self-association: identification of the binding domain.

Authors:  Carmen M Pérez-Ferreiro; Eva Lospitao; Isabel Correas
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

6.  Structural protein 4.1 is located in mammalian centrosomes.

Authors:  S W Krauss; J A Chasis; C Rogers; N Mohandas; G Krockmalnic; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  A Golgi-associated protein 4.1B variant is required for assimilation of proteins in the membrane.

Authors:  Qiaozhen Kang; Ting Wang; Huizheng Zhang; Narla Mohandas; Xiuli An
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

Review 8.  Communication between the cell membrane and the nucleus: role of protein compartmentalization.

Authors:  S A Lelièvre; M J Bissell
Journal:  J Cell Biochem Suppl       Date:  1998

Review 9.  Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

Authors:  E J Benz; S C Huang
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

10.  Protein 4.1N is required for the formation of the lateral membrane domain in human bronchial epithelial cells.

Authors:  Yaomei Wang; Huizhen Zhang; Qiaozhen Kang; Jing Liu; Haibo Weng; Wei Li; Narla Mohandas; Xiuli An; Lixiang Chen
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-02-08       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.